These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27861788)

  • 1. Phenotypically resembling myeloid derived suppressor cells are increased in children with HIV and exposed/infected with Mycobacterium tuberculosis.
    Du Plessis N; Jacobs R; Gutschmidt A; Fang Z; van Helden PD; Lutz MB; Hesseling AC; Walzl G
    Eur J Immunol; 2017 Jan; 47(1):107-118. PubMed ID: 27861788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytic-Myeloid Derived Suppressor Cells of HIV-Infected Individuals With Viral Suppression Exhibit Suppressed Innate Immunity to
    Namdev P; Patel S; Sparling B; Garg A
    Front Immunol; 2021; 12():647019. PubMed ID: 33995365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytic myeloid-derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase-2 inhibitors.
    Jøntvedt Jørgensen M; Jenum S; Tonby K; Mortensen R; Walzl G; Du Plessis N; Dyrhol-Riise AM
    J Leukoc Biol; 2021 Jul; 110(1):177-186. PubMed ID: 33155730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
    Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
    mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease.
    Grassi G; Vanini V; De Santis F; Romagnoli A; Aiello A; Casetti R; Cimini E; Bordoni V; Notari S; Cuzzi G; Mosti S; Gualano G; Palmieri F; Fraziano M; Goletti D; Agrati C; Sacchi A
    Front Immunol; 2021; 12():594376. PubMed ID: 33981297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function.
    du Plessis N; Loebenberg L; Kriel M; von Groote-Bidlingmaier F; Ribechini E; Loxton AG; van Helden PD; Lutz MB; Walzl G
    Am J Respir Crit Care Med; 2013 Sep; 188(6):724-32. PubMed ID: 23885784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis.
    Magcwebeba T; Dorhoi A; du Plessis N
    Front Immunol; 2019; 10():917. PubMed ID: 31114578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report.
    Davids M; Pooran A; Smith L; Tomasicchio M; Dheda K
    Front Immunol; 2021; 12():676679. PubMed ID: 34149712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Antimicrobial Activity of Monocytic Myeloid-Derived Suppressor Cells in Infection with Mycobacterium tuberculosis and Human Immunodeficiency Virus.
    Garg A
    Methods Mol Biol; 2021; 2236():115-127. PubMed ID: 33237545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of Infected Gr-1
    Abdissa K; Nerlich A; Beineke A; Ruangkiattikul N; Pawar V; Heise U; Janze N; Falk C; Bruder D; Schleicher U; Bogdan C; Weiss S; Goethe R
    Front Immunol; 2018; 9():2317. PubMed ID: 30386330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of autophagy mediators in myeloid-derived suppressor cells during human tuberculosis.
    Kotze LA; Leukes VN; Fang Z; Lutz MB; Fitzgerald BL; Belisle J; Loxton AG; Walzl G; du Plessis N
    Cell Immunol; 2021 Nov; 369():104426. PubMed ID: 34469846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoleamine-2,3-dioxygenase inhibition improves immunity and is safe for concurrent use with cART during Mtb/SIV coinfection.
    Singh B; Sharan R; Ravichandran G; Escobedo R; Shivanna V; Dick EJ; Hall-Ursone S; Arora G; Alvarez X; Singh DK; Kaushal D; Mehra S
    JCI Insight; 2024 Jul; 9(15):. PubMed ID: 39114981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium tuberculosis and myeloid-derived suppressor cells: Insights into caveolin rich lipid rafts.
    Kotzé LA; Young C; Leukes VN; John V; Fang Z; Walzl G; Lutz MB; du Plessis N
    EBioMedicine; 2020 Mar; 53():102670. PubMed ID: 32113158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
    Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
    Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.
    Dorhoi A; Kotzé LA; Berzofsky JA; Sui Y; Gabrilovich DI; Garg A; Hafner R; Khader SA; Schaible UE; Kaufmann SH; Walzl G; Lutz MB; Mahon RN; Ostrand-Rosenberg S; Bishai W; du Plessis N
    J Clin Invest; 2020 Jun; 130(6):2789-2799. PubMed ID: 32420917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses.
    Amelio P; Portevin D; Hella J; Reither K; Kamwela L; Lweno O; Tumbo A; Geoffrey L; Ohmiti K; Ding S; Pantaleo G; Daubenberger C; Perreau M
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive Features of the Microenvironment in Lymph Nodes Granulomas from Tuberculosis and HIV-Co-Infected Patients.
    Ashenafi S; Muvva JR; Mily A; Snäll J; Zewdie M; Chanyalew M; Rehn A; Rahman S; Aseffa G; Bekele A; Aderaye G; Lema B; Svensson M; Brighenti S
    Am J Pathol; 2022 Apr; 192(4):653-670. PubMed ID: 35092727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiological investigation for tuberculosis among HIV-infected children in Soweto, South Africa.
    Fairlie L; Muchiri E; Beylis CN; Meyers T; Moultrie H
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):676-81. PubMed ID: 24903938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis.
    Leukes V; Walzl G; du Plessis N
    Front Immunol; 2020; 11():451. PubMed ID: 32269568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.